• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Verastem, Inc. - Common Stock (NQ:VSTM)

4.210 +0.060 (+1.45%)
Streaming Delayed Price Updated: 11:24 AM EDT, May 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Verastem, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
October 20, 2021
Gainers Tenet Healthcare (NYSE:THC) stock r... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
September 27, 2021
Gainers Paratek Pharmaceuticals (NASDAQ:PRTK... 
Via Benzinga
News headline image
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 24, 2021
From Verastem Oncology
Via Business Wire
News headline image
Verastem Oncology Appoints Louis J. Denis, M.D., as Chief Medical Officer
September 22, 2021
From Verastem Oncology
Via Business Wire
News headline image
Why Verastem Stock Spiked Today ↗
September 20, 2021
A clinical collaboration with biotech titan Amgen briefly lit a fire underneath Verastem's shares today. 
Via The Motley Fool
News headline image
Why Verastem Shares Are Trading Higher Today ↗
September 20, 2021
Verastem Inc (NASDAQ: VSTM) is trading higher Monday after the company announced updated investigator-sponsored Phase 1/2 FRAME study data of VS-6766 with defactinib in low-... 
Via Benzinga
News headline image
35 Stocks Moving In Monday's Mid-Day Session ↗
September 20, 2021
Gainers ZIVO Bioscience, Inc. (NASDAQ: ZIVO) jumped 145% to $6.86 after declining around 17% on Friday. Edesa Biotech, Inc. (NASDAQ: EDSA) jumped 30.6% to $7.68 after the company... 
Via Benzinga
News headline image
Penny Biotech Stocks: 8 Things for Verastem Investors to Know as VSTM Stock Shoots Higher ↗
September 20, 2021
Verastem (VSTM) stock is on the rise Monday morning following an announcement from the company concerning a deal with Amgen (AMGN). 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
September 20, 2021
Gainers Verastem (NASDAQ:VSTM) shares moved upwards by 22.1% to $3.37 during Monday's pre-market session. The company's market cap stands at $609.1 million.... 
Via Benzinga
News headline image
24 Stocks Moving in Monday's Pre-Market Session ↗
September 20, 2021
Gainers Verastem, Inc. (NASDAQ: VSTM) rose 30.8% to $3.61 in pre-market trading after the company announced a mini oral presentation highlighting updated data from the ongoing... 
Via Benzinga
News headline image
Verastem Oncology and Amgen Partner to Evaluate VS-6766 in Combination with LUMAKRASTM (Sotorasib) in Patients with KRAS G12C-Mutant Non-Small Cell Lung Cancer
September 20, 2021
From Verastem Oncology
Via Business Wire
News headline image
Verastem Shares Are Trading Higher On Encouraging Combo Therapy Data At ESMO Presentation ↗
September 20, 2021
Verastem Oncology Inc (NASDAQ: VSTM) stock is trading higher after updated data from the ongoing Phase 1/2 FRAME study. The investigator-sponsored study is... 
Via Benzinga
News headline image
Verastem Oncology Announces Updated Investigator-Sponsored Phase 1/2 FRAME Study Data of VS-6766 with Defactinib in Low-Grade Serous Ovarian Cancer Showing Encouraging Response Rates and Progression-Free Survival Presented at ESMO 2021
September 19, 2021
From Verastem Oncology
Via Business Wire
News headline image
The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight ↗
September 19, 2021
Biotech stocks declined for the week ending Sept. 17, extending the losses from the previous week. European Society for Medical Oncology presentations, vaccine news, clinical... 
Via Benzinga
News headline image
Verastem Oncology to Present at Upcoming Investor Conferences
September 07, 2021
From Verastem Oncology
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
August 03, 2021
Gainers Outlook Therapeutics (NASDAQ:OTLK) shares increased by 38.49% to $3.13 during Tuesday's pre-market session. The company's market cap stands at $543.3... 
Via Benzinga
News headline image
Verastem Oncology Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
August 02, 2021
From Verastem Oncology
Via Business Wire
News headline image
Verastem Oncology Announces Updated Phase 1/2 FRAME Study Data in Low Grade Serous Ovarian Cancer Selected for a Mini Oral Presentation at the European Society of Medical Oncology Congress 2021
July 27, 2021
From Verastem Oncology
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
July 26, 2021
Gainers Dynatronics (NASDAQ:DYNT) shares moved upwards by 40.31% to $1.81 during Monday's pre-market session. The company's market cap stands at $31.4 million.... 
Via Benzinga
News headline image
Verastem Oncology Announces Conversion of Senior Notes Eliminating Substantially All Outstanding Debt
July 19, 2021
From Verastem Oncology
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
July 12, 2021
Gainers Celldex Therapeutics (NASDAQ:CLDX) stock rose 41.93% to $46.0 during Monday's pre-market session. The company's market cap stands at $1.8 billion. 180 Life... 
Via Benzinga
News headline image
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 06, 2021
From Verastem Oncology
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2021 ↗
July 01, 2021
Upgrades Citigroup upgraded the previous rating for Thor Industries Inc (NYSE: 
Via Benzinga
News headline image
Verastem Oncology Appoints Paul Bunn, M.D., and Lesley Solomon to Board of Directors
June 24, 2021
From Verastem Oncology
Via Business Wire
News headline image
44 Biggest Movers From Yesterday ↗
June 23, 2021
Gainers Alfi, Inc. (NASDAQ: ALF) shares jumped 108.9% to settle at $16.29 on Tuesday following exclusive Benzinga reporting the company will buyback up to $2 million of its... 
Via Benzinga
News headline image
2 Biotech Penny Stocks That Are Vastly Superior Investments to Dogecoin ↗
June 21, 2021
These unloved cancer stocks should dramatically outperform Dogecoin over the long haul. 
Via The Motley Fool
News headline image
Stocks That Hit 52-Week Highs On Wednesday ↗
June 16, 2021
Before 10 a.m. ET on Wednesday, 105 companies hit new 52-week highs. Interesting Facts: Toyota Motor (NYSE:TM) was the largest firm by market cap to set a new 52-... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
June 15, 2021
Gainers NeuroMetrix (NASDAQ:NURO) stock r... 
Via Benzinga
News headline image
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda ↗
June 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Highs On Monday ↗
June 14, 2021
During Monday's morning session, 255 companies made new 52-week highs. Points of Interest: The largest company by market cap to set a new 52-week high was Adobe (... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap